BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18435854)

  • 1. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
    Howlin J; Rosenkvist J; Andersson T
    Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
    Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
    Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.
    Troschel FM; Minte A; Ismail YM; Kamal A; Abdullah MS; Ahmed SH; Deffner M; Kemper B; Kiesel L; Eich HT; Ibrahim SA; Götte M; Greve B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
    Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
    J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells.
    Golubovskaya V; Beviglia L; Xu LH; Earp HS; Craven R; Cance W
    J Biol Chem; 2002 Oct; 277(41):38978-87. PubMed ID: 12167618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.
    Konstantinovsky S; Davidson B; Reich R
    Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer.
    Wu X; Zahari MS; Renuse S; Kelkar DS; Barbhuiya MA; Rojas PL; Stearns V; Gabrielson E; Malla P; Sukumar S; Mahajan NP; Pandey A
    Oncotarget; 2017 Jan; 8(2):2971-2983. PubMed ID: 27902967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kindlin-2 interacts with and stabilizes EGFR and is required for EGF-induced breast cancer cell migration.
    Guo B; Gao J; Zhan J; Zhang H
    Cancer Lett; 2015 Jun; 361(2):271-81. PubMed ID: 25790908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation.
    Wang Y; Deng W; Zhang Y; Sun S; Zhao S; Chen Y; Zhao X; Liu L; Du J
    Acta Physiol (Oxf); 2018 Feb; 222(2):. PubMed ID: 28719045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.
    Paris L; Cecchetti S; Spadaro F; Abalsamo L; Lugini L; Pisanu ME; Iorio E; Natali PG; Ramoni C; Podo F
    Breast Cancer Res; 2010; 12(3):R27. PubMed ID: 20462431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.
    Salazar N; Muñoz D; Kallifatidis G; Singh RK; Jordà M; Lokeshwar BL
    Mol Cancer; 2014 Aug; 13():198. PubMed ID: 25168820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
    Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
    J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNK2 promoted esophageal cancer progression via activating egfr-akt signaling.
    Zhang A; Zhang R; Yang Z; Tian R
    J Clin Lab Anal; 2021 Mar; 35(3):e23700. PubMed ID: 33484472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
    Xue L; Su D; Li D; Gao W; Yuan R; Pang W
    Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TNK2-AS1 regulated ox-LDL-stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR-150-5p.
    Cai T; Cui X; Zhang K; Zhang A; Liu B; Mu JJ
    J Cell Mol Med; 2019 Nov; 23(11):7289-7298. PubMed ID: 31468685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer.
    Kyriakopoulou K; Riti E; Piperigkou Z; Koutroumanou Sarri K; Bassiony H; Franchi M; Karamanos NK
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.